SCHEMBL19398196

SCHEMBL19398196

CNC(=O)N/C=C/c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.61
▸ NPC1 O15118 6/20 0.61
▸ SMN1; SMN2 Q16637 5/20 0.61
▸ RAB9A P51151 4/20 0.61
▸ HDAC1 Q13547 4/20 0.59
▸ HDAC2 Q92769 3/20 0.59
▸ HDAC6 Q9UBN7 3/20 0.59
▸ MAPT P10636 3/20 0.57
▸ LMNA P02545 3/20 0.57
▸ MEN1 O00255 2/20 0.57
▸ KMT2A Q03164 2/20 0.57
▸ KDM4E B2RXH2 1/20 0.57
▸ ABCG2 Q9UNQ0 1/20 0.48
▸ GLA P06280 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ HDAC3 O15379 2/20 0.46
▸ HDAC4 P56524 2/20 0.46
▸ HDAC8 Q9BY41 2/20 0.46
▸ RECQL P46063 2/20 0.45
▸ TNKS O95271 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22284093 1.00 ALDH1A1 (0.61) ALDH1A1NPC1SMN1; SMN2RAB9AHDAC1
SCHEMBL19403902 0.84 HDAC1 (0.79) ALDH1A1NPC1SMN1; SMN2RAB9AHDAC1
SCHEMBL6208267 0.80 ALDH1A1 (0.47) ALDH1A1NPC1SMN1; SMN2RAB9AHDAC1
SCHEMBL1506725 0.80 NPC1 (0.63) ALDH1A1NPC1SMN1; SMN2RAB9AHDAC1
SCHEMBL6025421 0.80 NPC1 (0.63) ALDH1A1NPC1SMN1; SMN2RAB9AHDAC1
SCHEMBL27530558 0.79 NPC1 (0.68) ALDH1A1NPC1SMN1; SMN2RAB9AHDAC1
SCHEMBL19398197 0.79 ALDH1A1 (0.79) ALDH1A1NPC1SMN1; SMN2RAB9AHDAC1
SCHEMBL17664262 0.79 ALDH1A1 (0.84) ALDH1A1NPC1SMN1; SMN2RAB9AHDAC1
Bicarbonate SCHEMBL4307552 0.78 NPC1 (0.55) ALDH1A1NPC1SMN1; SMN2RAB9AHDAC1
Bicarbonate SCHEMBL6421261 0.78 NPC1 (0.55) ALDH1A1NPC1SMN1; SMN2RAB9AHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170273922-A1 UREA AND BIS-UREA BASED COMPOUNDS AND ANALOGUES THEREOF USEFUL IN THE TREATMENT OF ANDROGEN RECEPTOR MEDIATED DISEASES OR DISORDERS THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2017-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170273922-A1 UREA AND BIS-UREA BASED COMPOUNDS AND ANALOGUES THEREOF USEFUL IN THE TREATMENT OF ANDROGEN RECEPTOR MEDIATED DISEASES OR DISORDERS AR, UTS2R, SHBG ALDH1A1 1583/4885NPC1 2234/4885SMN1; SMN2 3381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback